glutathione therapy from prodrugs to genes

glutathione therapy from prodrugs to genes Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer Synthetic prodrug design enables biocatalytic

Name: glutathione therapy from prodrugs to genes Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer Synthetic prodrug design enables biocatalytic
Brand: everengland.com
SKU: 20503895808
Price: 25.79 USD
Availability: InStock
Rating: 4.3861 (14 reviews)

Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression Nature Communications Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits PMC Adaptive epigenetic response of glutathione (GSH) related genes against lead (Pb) induced toxicity, in individuals chronically exposed to the metal ScienceDirect Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega

SKU: 20503895808 · From everengland.com

4.4

USD25.79 USD53.79

Pay in 4 interest-free payments of $6.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Ci thin cc vn v da do nh nng mt tri v tc hi ca mi trng, ng thi ci thin sc t, sm da v tn nhang, chng np nhn, ngn chn qu trnh lo ha

Zinellu E, Zinellu A, Fois AG, Fois SS, Piras B, Carru C, et al

Goldstein DB

In another embodiment, the invention provides genetic vaccines that include: a) an optimized recombinant binding moiety that comprises a nucleic acid binding domain and a cell-specific ligand, and b) a polynucleotide sequence that comprises a binding site, wherein the nucleic acid binding domain is capable of specifically binding to the binding site